source
- Recon: Merck KGaA to exit CDMO business; Karyopharm to sell itself in bankruptcyWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 7d ago↗ source
- WuXi Biologics and Fresenius strike major deal for up to 37 biosimilars over the next decadeWuXi Biologics and German drugmaker Fresenius have agreed to collaborate on the development and manufacturing of up to 37 biosimilar medicines over the next ten years. The agreement is described a…